These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 19900619

  • 1. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
    Tao J, Wu H, Sun YE.
    Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
    [Abstract] [Full Text] [Related]

  • 2. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y, Kusaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E, Higashi H, Matsuishi T, Kosai K.
    Brain Res; 2010 Nov 11; 1360():17-27. PubMed ID: 20816763
    [Abstract] [Full Text] [Related]

  • 3. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M, Sáez MA, Kang D, Zoghbi HY, Young JI.
    Hum Mol Genet; 2007 Oct 01; 16(19):2315-25. PubMed ID: 17635839
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
    Francke U.
    Nat Clin Pract Neurol; 2006 Apr 01; 2(4):212-21. PubMed ID: 16932552
    [Abstract] [Full Text] [Related]

  • 5. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M, Zoghbi HY.
    Neuron; 2007 Nov 08; 56(3):422-37. PubMed ID: 17988628
    [Abstract] [Full Text] [Related]

  • 6. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P, Zoghbi HY.
    Curr Opin Genet Dev; 2006 Jun 08; 16(3):276-81. PubMed ID: 16647848
    [Abstract] [Full Text] [Related]

  • 7. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM.
    Biol Psychiatry; 2006 Mar 01; 59(5):468-76. PubMed ID: 16199017
    [Abstract] [Full Text] [Related]

  • 8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.
    J Neuropathol Exp Neurol; 2007 Feb 01; 66(2):117-23. PubMed ID: 17278996
    [Abstract] [Full Text] [Related]

  • 9. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE, Johnston MV, Blue ME.
    Brain Dev; 2005 Nov 01; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [Abstract] [Full Text] [Related]

  • 10. Rett syndrome: from the gene to the disease.
    Matijevic T, Knezevic J, Slavica M, Pavelic J.
    Eur Neurol; 2009 Nov 01; 61(1):3-10. PubMed ID: 18948693
    [Abstract] [Full Text] [Related]

  • 11. MeCP2 in neurons: closing in on the causes of Rett syndrome.
    Caballero IM, Hendrich B.
    Hum Mol Genet; 2005 Apr 15; 14 Spec No 1():R19-26. PubMed ID: 15809268
    [Abstract] [Full Text] [Related]

  • 12. MeCP2: structure and function.
    Adkins NL, Georgel PT.
    Biochem Cell Biol; 2011 Feb 15; 89(1):1-11. PubMed ID: 21326358
    [Abstract] [Full Text] [Related]

  • 13. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS, Tsujimoto N, Qu Q, Lei H, Li E, Chen T, Blaustein CS.
    Neuroreport; 2008 Mar 05; 19(4):393-8. PubMed ID: 18287934
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA, Schaevitz LR, Bowling H, Nag N, Berger UV, Berger-Sweeney J.
    Neuroscience; 2007 May 25; 146(3):907-21. PubMed ID: 17383101
    [Abstract] [Full Text] [Related]

  • 15. MeCP2 post-translational regulation through PEST domains: two novel hypotheses: potential relevance and implications for Rett syndrome.
    Thambirajah AA, Eubanks JH, Ausió J.
    Bioessays; 2009 May 25; 31(5):561-9. PubMed ID: 19319913
    [Abstract] [Full Text] [Related]

  • 16. MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively.
    Palmer A, Qayumi J, Ronnett G.
    Mol Cell Neurosci; 2008 Apr 25; 37(4):794-807. PubMed ID: 18295506
    [Abstract] [Full Text] [Related]

  • 17. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF, Bird A.
    Ment Retard Dev Disabil Res Rev; 2002 Apr 25; 8(2):87-93. PubMed ID: 12112733
    [Abstract] [Full Text] [Related]

  • 18. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK, Bailey ME, Cobb SR.
    Biochem J; 2011 Oct 01; 439(1):1-14. PubMed ID: 21916843
    [Abstract] [Full Text] [Related]

  • 19. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
    Philippe C, Villard L, De Roux N, Raynaud M, Bonnefond JP, Pasquier L, Lesca G, Mancini J, Jonveaux P, Moncla A, Chelly J, Bienvenu T.
    Eur J Med Genet; 2006 Oct 01; 49(1):9-18. PubMed ID: 16473305
    [Abstract] [Full Text] [Related]

  • 20. Identification of cis-regulatory elements for MECP2 expression.
    Liu J, Francke U.
    Hum Mol Genet; 2006 Jun 01; 15(11):1769-82. PubMed ID: 16613900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.